Projected Income Statement: Evolus, Inc.

Forecast Balance Sheet: Evolus, Inc.

Forecast Balance Sheet - Evolus, Inc.
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 - 20.5 57.5 - 92.3 121 126 111
Change - - 180.49% - - 31.14% 4.13% -11.9%
Announcement Date 3/3/22 3/8/23 3/7/24 3/4/25 3/3/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Evolus, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 0.393 1.618 1.627 4.823 8.452 3 4 4
Change - 311.7% 0.56% 196.44% 75.24% -64.51% 33.33% 0%
Free Cash Flow (FCF) 1 - -86.53 -34.48 -22.82 -50.72 -25.5 -1.5 22
Change - - 60.15% 33.81% -122.23% 49.72% 94.12% 1,566.67%
Announcement Date 3/3/22 3/8/23 3/7/24 3/4/25 3/3/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Evolus, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - -42.94% -28.95% -11.57% 0.09% -4.23% 3.08% 9.23% 14.7%
EBIT Margin (%) - -44.55% -43.96% -24.36% -12.92% -10.99% -3.83% 2.58% 8.8%
EBT Margin (%) - -46.92% -50.01% -30.44% -18.69% -17.15% -8.87% -1.35% 5.32%
Net margin (%) - -46.96% -50.07% -30.52% -18.94% -17.38% -9.45% -2.31% 4.04%
FCF margin (%) - - -58.22% -17.06% -8.57% -17.07% -7.63% -0.38% 4.76%
FCF / Net Income (%) - - 116.29% 55.9% 45.26% 98.21% 80.75% 16.58% 117.74%

Profitability

         
ROA -19.1% -17.04% -16.53% -12.3% -8.08% -10.25% - - -
ROE -5,016.56% -1,049.79% -148.27% 5,633.33% 664.86% 587.36% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - -0.48x -2.46x - -7.35x 11.75x 3.48x 1.63x
Debt / Free cash flow - - -0.24x -1.67x - -1.82x -4.75x -84x 5.05x

Capital Intensity

         
CAPEX / Current Assets (%) - 0.39% 1.09% 0.81% 1.81% 2.84% 0.9% 1.02% 0.86%
CAPEX / EBITDA (%) - -0.92% -3.76% -6.96% 1,929.2% -67.31% 29.14% 11.05% 5.88%
CAPEX / FCF (%) - - -1.87% -4.72% -21.13% -16.67% -11.76% -266.67% 18.18%

Items per share

         
Cash flow per share 1 - - -1.514 - -0.2902 -0.6556 -0.05 0.27 0.68
Change - - - - - -125.91% 92.37% 640% 151.85%
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - 0.3288 -0.3578 0.087 -0.3554 -0.9 -1.1 -0.8
Change - - - -208.82% 124.32% -508.51% -153.24% -22.22% 27.27%
EPS 1 - -0.94 -1.33 -1.08 -0.81 -0.8 -0.492 -0.156 0.24
Change - - -41.49% 18.8% 25% 1.23% 38.5% 68.29% 253.85%
Nbr of stocks (in thousands) - 55,577 56,247 57,761 63,321 64,820 66,050 66,050 66,050
Announcement Date - 3/3/22 3/8/23 3/7/24 3/4/25 3/3/26 - - -
1USD
Estimates
2026 *2027 *
P/E -15.5x -48.9x
PBR -8.48x -6.94x
EV / Sales 1.87x 1.61x
Yield - -

EPS & Dividend

EPS & Dividend - Evolus, Inc.


Y-o-Y evolution of P/E

Valuation ratios - P/E - Evolus, Inc.
 
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
MarketScreener Ratings - Evolus, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
7.635USD
Average target price
15.00USD
Spread / Average Target
+96.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Evolus, Inc.
  1. Stock Market
  2. Stocks
  3. EOLS Stock
  4. Financials Evolus, Inc.